Addition Therapeutics

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives

Board Members

Investors

Total Funding

$187.5M

Investors

11 investors across all rounds

Abingworth

Berkeley

BEVC (Berkeley)

Gates Foundation

Nan Fung Life Sciences

+6 more investors

Explore More Data

Detailed analysis for Addition Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

Addition Therapeutics Leadership & Investors

Addition Therapeutics is led by a team of experienced leaders. The company has attracted investment from 11 institutional and strategic investors.

Who Has Invested in Addition Therapeutics?

Addition Therapeutics has raised $187.5M from 11 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access Addition Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.